Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
buprenorphine (2 trials)
emtricitabine (emtriva) (1 trial)
lopinavir (Kaletra) (1 trial)
ritonavir (Norvir) (1 trial)
tenofovir (viread) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
naloxone (narcan) (1 trial)
HIV Infections (Phase 2)
Opioid-Related Disorders (Phase 4)
Trials (3 total)
Trial APIs (7 total)